Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report

Intravitreal Dexamethasone Implant in the Treatment of Refractory Uveitic Macular Edema: A Case Report

Blog Article

Macular edema is the most common cause of vision loss in uveitis.It can respond to systemic or Foodcover local steroids administered as either subtenon depot or intravitreal injection.Ozurdex (Allergan Pharmaceuticals) is a biodegradable dexamethasone intravitreal implant that contains 0.

7mg of dexamethasone.It received FDA approval in September 2010 for the treatment of non-infectious posterior uveitis.It has been Ball - Catcher - Helmets used and found to be efficacious and safe in persistent uveitic macular edema in both vitrectomised and non-vitrectomised eyes.

We describe a case of persistent uveitic macular edema without active intraocular inflammation resolving with a single injection of ozurdex.